Washington University in St Louis-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Washington University in St Louis - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013271
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Washington University in St Louis (Washington University), a subsidiary of University of Washington is an educational university that provides patient care and research services in the US. The university provides various courses of bachelor’s, master’s, and doctoral degrees in a wide range of traditional and interdisciplinary fields. It provides degree programs in the areas of law, engineering, education, business and international affairs, medicine, public health, and others. The university’s schools include School of Engineering & Applied Science, Sam Fox School of Design and Visual Arts, George Warren Brown School of Social Work, and others. Washington University is headquartered in St. Louis, Missouri, the US.

Washington University in St Louis – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Washington University in St Louis, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Washington University in St Louis, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Washington University in St Louis, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Washington University in St Louis, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Washington University in St Louis, Medical Devices Deals, 2011 to YTD 2017 9
Washington University in St Louis, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Washington University in St Louis, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Pfizer Enters into Agreement with Washington University in St. Louis 12
GenVec Enters into Agreement with Washington University in St. Louis 13
MaxCyte Enters into Agreement with Washington University in St Louis 14
Turing Pharma Enters into Partnership with Washington University 15
Johnson & Johnson Innovation Enters into Research Agreement with Washington University 16
GenVec Enters into Agreement with Washington University at St. Louis 17
Cumberland Emerging Technologies Enters Into Agreement With Washington University in St. Louis 18
Licensing Agreements 19
ViewPoint Therapeutics Receives Technology Rights from University of Michigan and Washington University 19
Sage Therapeutics Enters Into Licensing Agreement With Washington University To Develop Gaba Receptor Small Molecules 20
ChromaDex Enters Into Licensing Agreement With Washington University For Nicotinamide Riboside 21
Fimbrion Therapeutics Enters into Licensing Agreement with Washington University 22
Washington University in St Louis – Key Competitors 23
Washington University in St Louis – Key Employees 24
Washington University in St Louis – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Government and Public Interest 26
Nov 02, 2017: Lung Cancer Research Foundation Awards $1.6 Million in Research Grants 26
Oct 02, 2017: TSRI Researchers Join National Digital Health Informatics Collaborative 28
Sep 25, 2017: Human antibodies from dengue patients can effectively treat Zika infection in mice 29
Sep 25, 2017: Antibody protects against both Zika and dengue, mouse study shows 31
Mar 13, 2017: University Of Utah Engineers Use CRISPR Technology To Prevent Tissue Damage And Resulting Chronic Pain 33
Oct 04, 2016: Revolutionary Clinical Trial Initiative Focuses on Precision Medicine, Collaboration and Data Sharing to Transform Outcomes for All Pancreatic Cancer Patients 34
Sep 30, 2016: NHLBI Awards Grants to Help Improve Health Outcomes for Teens, Adults with Sickle Cell Disease 36
Sep 22, 2016: Kenneth Rainin Foundation Awards Over $3 Million to High-Risk, High Reward Inflammatory Bowel Disease Research Projects 37
May 31, 2016: Researchers create first 3-D mathematical model of uterine contractions 39
Clinical Trials 40
Oct 26, 2017: NIH study identifies new targets for anti-malaria drugs 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41

List of Tables
Washington University in St Louis, Pharmaceuticals & Healthcare, Key Facts 2
Washington University in St Louis, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Washington University in St Louis, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Washington University in St Louis, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Washington University in St Louis, Deals By Therapy Area, 2011 to YTD 2017 8
Washington University in St Louis, Medical Devices Deals, 2011 to YTD 2017 9
Washington University in St Louis, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Pfizer Enters into Agreement with Washington University in St. Louis 12
GenVec Enters into Agreement with Washington University in St. Louis 13
MaxCyte Enters into Agreement with Washington University in St Louis 14
Turing Pharma Enters into Partnership with Washington University 15
Johnson & Johnson Innovation Enters into Research Agreement with Washington University 16
GenVec Enters into Agreement with Washington University at St. Louis 17
Cumberland Emerging Technologies Enters Into Agreement With Washington University in St. Louis 18
ViewPoint Therapeutics Receives Technology Rights from University of Michigan and Washington University 19
Sage Therapeutics Enters Into Licensing Agreement With Washington University To Develop Gaba Receptor Small Molecules 20
ChromaDex Enters Into Licensing Agreement With Washington University For Nicotinamide Riboside 21
Fimbrion Therapeutics Enters into Licensing Agreement with Washington University 22
Washington University in St Louis, Key Competitors 23
Washington University in St Louis, Key Employees 24
Washington University in St Louis, Subsidiaries 25

★海外企業調査レポート[Washington University in St Louis-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Green Cross Cell Corp (031390):企業の財務・戦略的SWOT分析
    Green Cross Cell Corp (031390) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • SoCore Energy LLC:電力:M&Aディール及び事業提携情報
    Summary SoCore Energy LLC (SoCore Energy), a subsidiary of Edison International is a provider of solar solutions. The company’s services include solar energy development and installations, production monitoring, cost saving energy solutions, financing, procurement, technical and project management, …
  • Sotera Health LLC:医療機器:M&Aディール及び事業提携情報
    Summary Sotera Health LLC (Sotera Health), formerly Sterigenics International LLC, a subsidiary of GTCR LLC, is a medical device company. The company offers sterilization technologies such as gamma irradiation, electron beam and ethylene oxide. Its services include drug device combination, vaccine s …
  • Korea East-West Power Co Ltd:電力:M&Aディール及び事業提携情報
    Summary Korea East-West Power Co., Ltd. (EWP), subsidiary of Korea Electric Power Corporation, is a state-owned electric utility that generates and supplies electricity. It produces electricity from various sources including coal, oil, liquefied natural gas, mini hydro, and renewable sources such as …
  • Passenger Rail Agency of South Africa:企業の戦略的SWOT分析
    Passenger Rail Agency of South Africa - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • VirTra Inc (VTSI):企業の財務・戦略的SWOT分析
    VirTra Inc (VTSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • MMC Norilsk Nickel:企業の戦略・SWOT・財務情報
    MMC Norilsk Nickel - Strategy, SWOT and Corporate Finance Report Summary MMC Norilsk Nickel - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Asuragen Inc:医療機器:M&Aディール及び事業提携情報
    Summary Asuragen Inc (Asuragen) is an oncology molecular diagnostic company that provides laboratory medicine solutions. The company offers products such as amplidex, quantidex, and custom reagents. It provides custom and companion diagnostic services, which include commercialization, product approv …
  • Strategic Energy Resources Ltd (SER):石油・ガス:M&Aディール及び事業提携情報
    Summary Strategic Energy Resources Ltd (SER) is an oil and gas exploration and production company that acquires, explores, develops, and produces land prospective for oil and gas, graphite and mineral properties. The company operates its oil and gas projects in Gippsland basin in offshore Victoria. …
  • The Jean Coutu Group (PJC) Inc.:戦略・SWOT・企業財務分析
    The Jean Coutu Group (PJC) Inc. - Strategy, SWOT and Corporate Finance Report Summary The Jean Coutu Group (PJC) Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Naked Wines plc (WINE):企業の財務・戦略的SWOT分析
    Naked Wines plc (WINE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Cardinal Ethanol LLC:企業の戦略的SWOT分析
    Cardinal Ethanol LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • MakeMusic, Inc.:企業の戦略的SWOT分析
    MakeMusic, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • RCI Banque SA:企業の戦略的SWOT分析
    RCI Banque SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • V. F. Corporation:企業の戦略・SWOT・財務情報
    V. F. Corporation - Strategy, SWOT and Corporate Finance Report Summary V. F. Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Hexion Inc.:企業の戦略・SWOT・財務分析
    Hexion Inc. - Strategy, SWOT and Corporate Finance Report Summary Hexion Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Standardkessel Baumgarte Holding GmbH:企業の戦略的SWOT分析
    Standardkessel Baumgarte Holding GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Saskatchewan Telecommunications Holding Corporation:企業の戦略的SWOT分析
    Saskatchewan Telecommunications Holding Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key compe …
  • Moody’s Corporation:企業の戦略・SWOT・財務情報
    Moody's Corporation - Strategy, SWOT and Corporate Finance Report Summary Moody's Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Grupa Lotos SA (LTS):企業の財務・戦略的SWOT分析
    Grupa Lotos SA (LTS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆